Tourneau, C. L., Rolland, F., Capitain, O., Cassier, P. A., Fumet, J. D., Salas, S., Daste, A., Manso, L., Bermejo-Perez, M., Casado, A., Mansi, L., Pautier, P., Lantz, O., Dochy, E., Spring-Giusti, C., Huang, K. B., Makhloufi, H., Halluard, C., Tavernaro, A., Delord, J. (2025). Randomized phase II trial evaluating the combination of TG4001, an HPV16 therapeutic vaccine, and avelumab (ave) in patients (pts) with immunotherapy-naïve recurrent and/or metastatic (R/M) HPV16-positive cervical or anogenital cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2638